Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

ERCC1 and Ki67 in Small Cell Lung Carcinoma and Other Neuroendocrine Tumors of the Lung Distribution and Impact on Survival

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Changing Resistance Mechanisms in Rebiopsies of ALK-Positive NSCLC During Multiple Lines of Therapy: ALK/BRAF-Mutations Followed By EMT: P3.08-18

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  2. Locally Advanced Lung Cancer Radiotherapy in Deep Inspiration Breath Hold: Dosimetric Benefits from a Prospective Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Genetic Variation in GSTP1, Lung Function, Risk of Lung Cancer, and Mortality

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Use of Volume Growth and Fluor-Deoxy-Glucose Positron Emission Tomography in Evaluating Indeterminate Lung Nodules in Lung Cancer Screening

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  1. AHRR (cg05575921) methylation extent of leukocyte DNA and lung cancer survival

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Oxidized resorbable cellulose (Gelita-cel) causing foreign body reaction in the mediastinum

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Medicinsk behandling af lungecancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Background: Excision repair cross-complementation group 1 (ERCC1) is a key component of the platinum-DNA repair mechanism. Ki67 is associated with the clinical course of several malignancies. The associations of ERCC1 and Ki67, clinical features and survival in small cell lung carcinoma (SCLC), typical carcinoid (TC), atypical carcinoid (AC), and large cell neuroendocrine carcinoma (LCNEC) were determined. Materials and Methods: We included a consecutive series of 186 patients with SCLC treated with platinum-based chemotherapy and surgically treated patients with TC (n = 48), AC (n = 15) and LCNEC (n = 27). ERCC1 and Ki 67 were measured by immunohistochemistry and scored using published criteria. Results: The expression of ERCC1 was different among the different tumor types (p <0.001). For patient with limited disease as well as extensive disease SCLC, no association of ERCC1 expression with survival was observed (p = 0.59). However, only 10% of SCLC tumors expressed ERCC1. For TC and AC, ERCC1 positive patients had better survival than ERCC1 negative patients. ERCC1 had no prognostic impact for LCNEC. A difference of the percentage of Ki67 LI was observed for the different tumor types (p <0.001). The difference between TC and AC was significant (p = 0.02), as was the difference between low grade (TC + AC) and high grade NE (LCNEC + SCLC) (p <0.001). For all included patients, a correlation between Ki67 and ERCC1 was observed (RSquare = 0.19, p <0.001). Conclusion: ERCC1 expression in SCLC treated with platinum-based chemotherapy has no impact on survival. High expression of ERCC1 in TC might represent a clue to the failure of platinum-based therapy in these patients. ERCC1 expression has prognostic impact in lung carcinoids. Ki 67 might be considered as a supplementary test to the histopatologic classification of NE tumors
Original languageEnglish
JournalJournal of Thoracic Oncology
Volume5
Issue number4
Pages (from-to)453-459
Number of pages7
ISSN1556-0864
DOIs
Publication statusPublished - 2010

ID: 32288659